RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Final Results of an FDA-approved Prospective, Multicenter, Single-Arm Trial of Stent-Assisted Recanalization for Acute Ischemic Stroke
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 1
SP 14
OP 15
DO 10.1177/155989770901006
UL http://mdc.sagepub.com/content/9/1/14.abstract
AB Results from an FDA-approved, prospective pilot trial suggest that the use of a self-expanding, intracranial stent for acute stroke may achieve high levels of revascularization. This follows on the heels of the Mechanical Embolus Removal in Cerebral Ischemia [MERCI; NCT00318071] trials that reported recanalization rates that ranged from approximately 60% to 70% percent with low associated morbidity.